RxLibra

Home
Animal Health
Computational Biology
CXO
Labs
GenericMeds
NEWs
OriginalBrands
Biosimilars
TradeKown
ALL
Kindos
BrightGene
Eisai
Roche
BioRay
AnKeBio
LuNanPharm
HISUN
InnoventBio
Henlius
CHIATHAI TIANQIONG
TopAlliance
SinoCellTech
SinoPharm
BIO-THERA
JingZe
QiLu
Gensci
CenterGene
Alphamab
MSD&Merck
Assisted Reproduction
Business
Employee Incentive
Industry trends
Office
Payment
Shipping&Delivery

What kind of company is RxLibra?

RxLbra is a company in the biotechnology industry, and it is a Contract Transform Organization（CTO）.

Previously，RxLibra was originally founded during the Covid-19 pandemic as a cross-border service provider for the pharmaceutical industry.

What is the scope of RxLibra’s business?

RxLbra primarily aims to transfer the achievements of China’s biopharmaceutical industry to countries in the Global South, including but not limited to Southeast Asia, the Middle East, North Africa, and the Caucasus region.

What makes RxLibra’s business unique?

RxLibra’s business model is built on the “Labs to Patients” principle. The core of this model lies not in the innovation of the idea, but in the practical experience and industry resources that the RxLibra team has to do so.

What exactly can RxLibra do to help customers?

IP Acquisition: Assisting clients in identifying, evaluating, and acquiring intellectual property rights for innovative biotech products and technologies.
Sourcing of Biotech Equipment and Materials: Leveraging China’s manufacturing scale to source high-quality, cost-effective laboratory and clinical trial equipment, reagents, and consumables.
CXO Connections: Facilitating partnerships with leading Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), and other CXO entities to support R&D, manufacturing, and regulatory processes.
Field Trials and Clinical Support: Coordinating and supporting field trials, including site selection, patient recruitment, data management, and regulatory submissions in target markets.

What is the value proposition of a company like RxLibra?

For the sake of human well-being, academia and industry are exploring various ways to shorten the time from research and development to clinical application of new therapies, and using various means to improve the accessibility of new therapies, devices, and drugs. Accelerating the dissemination of technology and innovation is the reason RxLibra chose the word “Transform” to describe this professional and ongoing endeavor, and it is also the value  proposition of RxLibra.